Structure-activity relationship studies of three novel 4-aminopyridine K+ channel blockers
S. Rodriguez-Rangel, A. D. Bravin, K. M. Ramos-Torres, P. Brugarolas, J. E. Sanchez-Rodriguez
This study evaluates three novel 4-aminopyridine derivatives as potential PET imaging and therapeutic agents for KV1 channel blockade in multiple sclerosis.
bioRxiv · Aug 11, 2019Biophysics